Characteristics of inflammatory bowel disease in patients of Roma/Gypsy ethnicity. A case-control study

Dig Liver Dis. 2019 May;51(5):669-674. doi: 10.1016/j.dld.2018.12.004. Epub 2018 Dec 19.

Abstract

Background: Peculiarities of inflammatory bowel disease (IBD) have been explored in ethnic groups, such as Asians, Hispanics, and Afro-Americans, but not in other ethnic minorities, such as Roma/Gypsies.

Methods: In a retrospective, hospital-based study, all adult Roma/Gypsy patients included in the IBD databases of seven Spanish centres were identified as cases. For each Roma/Gypsy patient, a Caucasian patient, matched for several demographic features, was searched as a control. Data on phenotypic features, therapeutic requirements, and familial aggregation were recorded.

Results: Sixty-eight Roma/Gypsy patients were identified, 29 of them being women. The mean age at diagnosis of IBD was 24.9±9.5years, and the mean time elapsed since diagnosis was 96.6±72.2months. Roma/Gypsy IBD patients showed a significantly higher rate of familial aggregation (43%) than their Caucasian controls (9%) (p=0.00001). CD in Roma/Gypsies had more often a complicated pattern (mainly penetrating) while UC patients showed a marked trend to more often developing extraintestinal manifestations. In addition, Roma/Gypsy IBD patients had a somewhat greater need for immunosuppressants, biological agents or surgery.

Conclusions: These are the first data on IBD in Roma/Gypsy patients. Familial aggregation is the most prominent feature in these patients, suggesting a predominant role of genetics in its pathogenesis.

Keywords: Crohn’s Disease; Inflammatory Bowel Disease; Roma/Gypsy ethnicit; Ulcerative Colitis.

Publication types

  • Multicenter Study

MeSH terms

  • Adolescent
  • Adult
  • Case-Control Studies
  • Databases, Factual
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Inflammatory Bowel Diseases / ethnology*
  • Inflammatory Bowel Diseases / therapy
  • Male
  • Phenotype*
  • Roma / statistics & numerical data*
  • Spain / epidemiology
  • Young Adult

Substances

  • Immunosuppressive Agents